Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alpha Teknova Inc (NQ: TKNO )

2.690 +0.520 (+23.96%)
Streaming Delayed Price Updated: 10:49 AM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Alpha Teknova Inc

< Previous 1 2 Next >
Teknova Announces Closing of $15.4 Million Private Placement
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova Announces $15.4 Million Private Placement
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova Provides Strategic Business Update and Announces Preliminary Second Quarter 2024 Results
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova Reports First Quarter 2024 Financial Results
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova Launches Proprietary Build-Tek™ Solutions Custom Configurator and Latest AAV-Tek™ Product to Further Accelerate Novel Therapy Development
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova to Report First Quarter 2024 Financial Results on May 13, 2024
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova Reports Fourth Quarter and Full Year 2023 Financial Results
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
From Alpha Teknova, Inc.
Via GlobeNewswire
3 cheap stocks that insiders are buying
The stocks with the most active insider buying changed over the last month putting three new names in the spotlight; all are trading near historic lows. 
Via MarketBeat
Topics Initial Public Offering
Exposures Securities Market
Teknova Reports Third Quarter 2023 Financial Results
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova to Report Third Quarter 2023 Financial Results on November 9, 2023
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova Launches Latest Proprietary AAV-Tek™ Product and End-to-End Plasmid Workflow Solutions to Streamline Therapeutic Process Development
Novel AEX screening kit – now available for AAV6 – and an expansive suite of high-quality reagents designed to expedite plasmid production will help accelerate breakthroughs across multiple AAV... 
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova Announces Closing of $22.9 Million Concurrent Registered Direct Offering and Private Placement and Amends Credit Facility
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova Announces Up to $22.9 Million Concurrent Registered Direct Offering and Private Placement
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova Announces New Board Member, Martha J. Demski
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova Reports Second Quarter 2023 Financial Results
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova Announces Opening of New GMP-Certified Facility, Increasing Manufacturing Capacity for Custom, High-Quality Life Sciences Reagents
State-of-the-art facility in Hollister, California is designed to help bioprocessing and gene therapy companies scale from research to clinical production 
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova to Report Second Quarter 2023 Financial Results on August 10, 2023
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova and Sartorius BIA Separations Share Data Demonstrating Reliable and Scalable Approach for the Enhancement of AAV Full Capsid Enrichment with an Optimized AEX Platform
Results from the companies’ first collaboration show the successful achievement of more than 85% full AAV with 80-95% recoveries when pairing Sartorius BIA Separations’ monolithic purification platform... 
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova Expands Proprietary AAV-Tek™ Solutions Product Line to Deliver End-to-End Solutions for Gene Therapy Process Development
First-of-its-kind screening kit now available for AAV8 – along with a suite of high-quality reagents to support the entire AAV workflow – helping gene therapy developers save months in process... 
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova to Participate in Upcoming Investor Conference
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova Reports First Quarter 2023 Financial Results
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova to Present Data on Novel Products to Accelerate the Development of AAV Therapies at ASGCT 2023 Annual Meeting
Company will share their latest findings for custom product innovations aimed at addressing key gene therapy bioprocessing bottlenecks 
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova Announces Time Change for First Quarter 2023 Financial Results Conference Call on May 10, 2023
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova Launches Proprietary AAV-Tek™ Solutions Gene Therapy Product Line to Accelerate the Development of AAV Therapies
State-of-the-art screening kit – available for purchase today – could save months of process development time by helping gene therapy developers to identify the ideal buffer formulations for use during... 
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova to Report First Quarter 2023 Financial Results on May 10, 2023
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova Reports Fourth Quarter and Full Year 2022 Financial Results
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova and Sartorius BIA Separations Announce Collaboration to Address Critical Pain Point in Gene Therapy Process Development
An AAV chromatography platform plus optimized custom buffer formulations yields a state-of-the-art offering for increased AAV recovery 
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova to Report Fourth Quarter and Full Year 2022 Financial Results on March 15, 2023
From Alpha Teknova, Inc.
Via GlobeNewswire
Teknova to Participate in Upcoming Investor Conferences
From Alpha Teknova, Inc.
Via GlobeNewswire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.